Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.41 |
| ▸ | TOP1 | P11387 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30497936 | 1.00 | ADORA2A (0.50) | ADORA2ACYP19A1ALDH1A1SMN1; SMN2SCN9A | |
| SCHEMBL13327614 | 0.85 | ALDH1A1 (0.50) | ADORA2AALDH1A1SMN1; SMN2MAPTKDM4E | |
| SCHEMBL29446790 | 0.85 | KDM4E (0.53) | ADORA2AALDH1A1SMN1; SMN2MAPTKDM4E | |
| SCHEMBL30616770 | 0.85 | KDM4E (0.53) | ADORA2AALDH1A1SMN1; SMN2MAPTKDM4E | |
| SCHEMBL3318116 | 0.85 | KDM4E (0.53) | ADORA2AALDH1A1SMN1; SMN2MAPTKDM4E | |
| SCHEMBL30497940 | 0.81 | MAP2K4 (0.50) | ADORA2AALDH1A1SMN1; SMN2MAPTKDM4E | |
| SCHEMBL21644724 | 0.81 | MAP2K4 (0.50) | ADORA2AALDH1A1SMN1; SMN2MAPTKDM4E | |
| SCHEMBL16436822 | 0.81 | MEN1 (0.56) | ADORA2AALDH1A1MAPTKDM4EMAPK1 | |
| SCHEMBL13559025 | 0.81 | MEN1 (0.46) | ADORA2ACYP19A1ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL7258823 | 0.81 | CYP19A1 (0.47) | ADORA2ACYP19A1ALDH1A1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11362287-B2 | Luminescent cyclometalating tridentate ligand-containing gold(III) compounds with aryl auxiliary ligands for organic light-emitting devices and their preparation thereof | THE UNIVERSITY OF HONG KONG (HK) | 2022-06-14 | — | — | US | disclosed |
| US-20200044167-A1 | LUMINESCENT CYCLOMETALATING TRIDENTATE LIGAND-CONTAINING GOLD(III) COMPOUNDS WITH ARYL AUXILIARY LIGANDS FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION THEREOF | UNIV HONG KONG (HK) | 2020-02-06 | — | — | US | disclosed |
| CN-110088228-A | Luminescent gold (III) compound containing Cyclometalated tridentate ligand and its preparation for organic light emitting apparatus with aryl assistant ligand | 香港大学 | 2019-08-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200044167-A1 | LUMINESCENT CYCLOMETALATING TRIDENTATE LIGAND-CONTAINING GOLD(III) COMPOUNDS WITH ARYL AUXILIARY LIGANDS FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION THEREOF | CBR3, NR4A3, NR2C2 | ADORA2A 2665/4885CYP19A1 3781/4885ALDH1A1 4270/4885 |
| US-11362287-B2 | Luminescent cyclometalating tridentate ligand-containing gold(III) compounds with aryl auxiliary ligands for organic light-emitting devices and their preparation thereof | CBR3, NR4A3, NR2C2 | ADORA2A 2665/4885CYP19A1 3781/4885ALDH1A1 4270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.